{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:01:38Z","timestamp":1791615698963,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["B.SUB.23.182"],"award-info":[{"award-number":["B.SUB.23.182"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The kynurenine pathway (KP) of tryptophan degradation includes several compounds that reveal immunomodulatory properties. The present study aimed to investigate the alteration in KP metabolites in young women with autoimmune thyroiditis (AIT) and their associations with thyroid function. The thyroid function tests, antithyroid antibodies measurement and ultrasonography of the thyroid gland have been performed in 57 young women with AIT and 38 age-matched healthy controls. The serum levels of tryptophan, kynurenine (KYN) and its metabolites were determined, and the activity of KP enzymes was calculated indirectly as product-to-substrate ratios. KP was activated and dysregulated in AIT, along with significantly elevated levels of KYN and anthranilic acid (AA), at the expense of the reduction of kynurenic acid (KYNA), which was reflected by the increase in the AA\/KYNA ratio (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In univariate and multiple regression analyses, peripheral deiodinase (SPINA-GD) activity in AIT was positively associated with KYNA, AA, and quinolinic acid (QA). The merger of AA, AA\/KYNA ratio, QA and SPINA-GD exhibited the highest sensitivity and specificity to predict AIT (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) in receiver operating characteristic (ROC) analysis. In conclusion, the serum KYN metabolite profile is dysregulated in young women with AIT and could serve as a new predictor of AIT risk.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-57154-3","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:02:32Z","timestamp":1711033352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alteration in kynurenine pathway metabolites in young women with autoimmune thyroiditis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-1866","authenticated-orcid":false,"given":"Anna","family":"Krupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"\u0141ebkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kondraciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol Adam","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"57154_CR1","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli, M. et al. Hashimoto\u2019s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun. Rev. 19, 102649. https:\/\/doi.org\/10.1016\/j.autrev.2020.102649 (2020).","journal-title":"Autoimmun. Rev."},{"key":"57154_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli, P., De Remigis, A. & Rose, N. R. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun. Rev. 13, 391\u2013397. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007 (2014).","journal-title":"Autoimmun. Rev."},{"key":"57154_CR3","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","volume":"33","author":"F Ragusa","year":"2019","unstructured":"Ragusa, F. et al. Hashimotos\u2019 thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract. Res. Clin. Endocrinol. Metab. 33, 101367. https:\/\/doi.org\/10.1016\/j.beem.2019.101367 (2019).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"57154_CR4","doi-asserted-by":"publisher","first-page":"16222","DOI":"10.20452\/pamw.16222","volume":"132","author":"J Klubo-Gwiezdzinska","year":"2022","unstructured":"Klubo-Gwiezdzinska, J. & Wartofsky, L. Hashimoto thyroiditis: An evidence-based guide to etiology, diagnosis and treatment. Pol. Arch. Intern. Med. 132, 16222. https:\/\/doi.org\/10.20452\/pamw.16222 (2022).","journal-title":"Pol. Arch. Intern. Med."},{"key":"57154_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3803\/EnM.2016.31.2.213","volume":"31","author":"WM Wiersinga","year":"2016","unstructured":"Wiersinga, W. M. Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol. Metab. (Seoul) 31, 213\u2013222. https:\/\/doi.org\/10.3803\/EnM.2016.31.2.213 (2016).","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"57154_CR6","doi-asserted-by":"publisher","first-page":"774362","DOI":"10.3389\/fendo.2021.774362","volume":"12","author":"B Gong","year":"2021","unstructured":"Gong, B. et al. Association between gut microbiota and autoimmune thyroid disease: A systematic review and meta-analysis. Front. Endocrinol. 12, 774362. https:\/\/doi.org\/10.3389\/fendo.2021.774362 (2021).","journal-title":"Front. Endocrinol."},{"key":"57154_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/er.2013-1055","volume":"35","author":"SM McLachlan","year":"2014","unstructured":"McLachlan, S. M. & Rapoport, B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr. Rev. 35, 59\u2013105. https:\/\/doi.org\/10.1210\/er.2013-1055 (2014).","journal-title":"Endocr. Rev."},{"key":"57154_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15557\/JoU.2014.0005","volume":"14","author":"A Trzebi\u0144ska","year":"2014","unstructured":"Trzebi\u0144ska, A., Dobruch-Sobczak, K., Jakubowski, W. & J\u0119drzejowski, M. Standards of the Polish Ultrasound Society\u2014Update. Ultrasound examination of thyroid gland and ultrasound-guided thyroid biopsy. J. Ultrason. 14, 49\u201360. https:\/\/doi.org\/10.15557\/JoU.2014.0005 (2014).","journal-title":"J. Ultrason."},{"key":"57154_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41574-019-0218-2","volume":"15","author":"C Luongo","year":"2019","unstructured":"Luongo, C., Dentice, M. & Salvatore, D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat. Rev. Endocrinol. 15, 479\u2013488. https:\/\/doi.org\/10.1038\/s41574-019-0218-2 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"57154_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2022.09.024","volume":"193","author":"J K\u00f6hrle","year":"2022","unstructured":"K\u00f6hrle, J. & Fr\u00e4drich, C. Deiodinases control local cellular and systemic thyroid hormone availability. Free Radic. Biol. Med. 193, 59\u201379. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.024 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"57154_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00057","author":"JW Dietrich","year":"2016","unstructured":"Dietrich, J. W. et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front. Endocrinol. (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2016.00057 (2016).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"57154_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone, T. W. & Williams, R. O. Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends Pharmacol. Sci. 44, 442\u2013456. https:\/\/doi.org\/10.1016\/j.tips.2023.04.006 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"57154_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mehy.2018.06.021","volume":"118","author":"AA Badawy","year":"2018","unstructured":"Badawy, A. A. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease. Med. Hypotheses 118, 129\u2013138. https:\/\/doi.org\/10.1016\/j.mehy.2018.06.021 (2018).","journal-title":"Med. Hypotheses"},{"key":"57154_CR14","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.3390\/ijms22189879","volume":"22","author":"A Krupa","year":"2021","unstructured":"Krupa, A. & Kowalska, I. The kynurenine pathway-new linkage between innate and adaptive immunity in autoimmune endocrinopathies. Int. J. Mol. Sci. 22, 9879. https:\/\/doi.org\/10.3390\/ijms22189879 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"57154_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","volume":"11","author":"YS Huang","year":"2020","unstructured":"Huang, Y. S., Ogbechi, J., Clanchy, F. I., Williams, R. O. & Stone, T. W. IDO and kynurenine metabolites in peripheral and CNS disorders. Front. Immunol. 11, 388. https:\/\/doi.org\/10.3389\/fimmu.2020.00388 (2020).","journal-title":"Front. Immunol."},{"key":"57154_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3389\/fimmu.2019.02570","volume":"10","author":"FA Boros","year":"2019","unstructured":"Boros, F. A. & V\u00e9csei, L. Immunomodulatory effects of genetic alterations affecting the kynurenine pathway. Front. Immunol. 10, 2570. https:\/\/doi.org\/10.3389\/fimmu.2019.02570 (2019).","journal-title":"Front. Immunol."},{"key":"57154_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130715","volume":"10","author":"R Mancuso","year":"2015","unstructured":"Mancuso, R. et al. Indoleamine 2,3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis. PLoS ONE 10, e0130715. https:\/\/doi.org\/10.1371\/journal.pone.0130715 (2015).","journal-title":"PLoS ONE"},{"key":"57154_CR18","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1038\/srep41473","volume":"7","author":"CK Lim","year":"2017","unstructured":"Lim, C. K. et al. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci. Rep. 7, 41473. https:\/\/doi.org\/10.1038\/srep41473 (2017).","journal-title":"Sci. Rep."},{"key":"57154_CR19","doi-asserted-by":"publisher","first-page":"104898","DOI":"10.1016\/j.msard.2023.104898","volume":"77","author":"SMT Is\u0131k","year":"2023","unstructured":"Is\u0131k, S. M. T. et al. Relationship of tryptophan metabolites with the type and severity of multiple sclerosis. Mult. Scler. Relat. Disord. 77, 104898. https:\/\/doi.org\/10.1016\/j.msard.2023.104898 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"57154_CR20","doi-asserted-by":"publisher","first-page":"104592","DOI":"10.1016\/j.msard.2023.104592","volume":"72","author":"M Kupjetz","year":"2023","unstructured":"Kupjetz, M. et al. The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis. Mult. Scler. Relat. Disord. 72, 104592. https:\/\/doi.org\/10.1016\/j.msard.2023.104592 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"57154_CR21","doi-asserted-by":"publisher","first-page":"e000808","DOI":"10.1136\/lupus-2022-000808","volume":"9","author":"EW Anderson","year":"2022","unstructured":"Anderson, E. W. et al. Associations between circulating interferon and kynurenine\/tryptophan pathway metabolites: Support for a novel potential mechanism for cognitive dysfunction in SLE. Lupus Sci. Med. 9, e000808. https:\/\/doi.org\/10.1136\/lupus-2022-000808 (2022).","journal-title":"Lupus Sci. Med."},{"key":"57154_CR22","doi-asserted-by":"publisher","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","volume":"5","author":"K \u00c5kesson","year":"2018","unstructured":"\u00c5kesson, K. et al. Kynurenine pathway is altered in patients with SLE and associated with severe fatigue. Lupus Sci. Med. 5, e000254. https:\/\/doi.org\/10.1136\/lupus-2017-000254 (2018).","journal-title":"Lupus Sci. Med."},{"key":"57154_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","volume":"51","author":"S Aeinehband","year":"2016","unstructured":"Aeinehband, S. et al. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms. Brain Behav. Immun. 51, 47\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.016 (2016).","journal-title":"Brain Behav. Immun."},{"key":"57154_CR24","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/cp4st9","author":"Y Park","year":"2023","unstructured":"Park, Y. et al. Kynurenine pathway can be a potential biomarker of fatigue in primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/cp4st9 (2023).","journal-title":"Clin. Exp. Rheumatol."},{"key":"57154_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2023.01.007","volume":"114","author":"D Eryavuz Onmaz","year":"2023","unstructured":"Eryavuz Onmaz, D. et al. Impaired kynurenine metabolism in patients with primary Sj\u00f6gren\u2019s syndrome. Clin. Biochem. 114, 1\u201310. https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.01.007 (2023).","journal-title":"Clin. Biochem."},{"key":"57154_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/labmed\/lmac084","volume":"54","author":"H Apayd\u0131n","year":"2023","unstructured":"Apayd\u0131n, H. et al. Elevated kynurenine levels in patients with primary Sj\u00f6gren\u2019s syndrome. Lab. Med. 54, 166\u2013172. https:\/\/doi.org\/10.1093\/labmed\/lmac084 (2023).","journal-title":"Lab. Med."},{"key":"57154_CR27","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39629","volume":"68","author":"NI Maria","year":"2016","unstructured":"Maria, N. I. et al. Association of increased Treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 68, 1688\u20131699. https:\/\/doi.org\/10.1002\/art.39629 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"57154_CR28","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jaci.2015.09.055","volume":"137","author":"JL Harden","year":"2016","unstructured":"Harden, J. L. et al. The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases. J. Allergy Clin. Immunol. 137, 1830\u20131840. https:\/\/doi.org\/10.1016\/j.jaci.2015.09.055 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"57154_CR29","doi-asserted-by":"publisher","first-page":"17025","DOI":"10.1038\/s41598-020-74183-w","volume":"10","author":"S G\u00fcrc\u00fc","year":"2020","unstructured":"G\u00fcrc\u00fc, S. et al. Neopterin and biopterin levels and tryptophan degradation in patients with diabetes. Sci. Rep. 10, 17025. https:\/\/doi.org\/10.1038\/s41598-020-74183-w (2020).","journal-title":"Sci. Rep."},{"key":"57154_CR30","doi-asserted-by":"publisher","DOI":"10.15761\/IMM.1000169","author":"G Oxenkrug","year":"2015","unstructured":"Oxenkrug, G., van der Hart, M. & Summergrad, P. Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus. Integr. Mol. Med. https:\/\/doi.org\/10.15761\/IMM.1000169 (2015).","journal-title":"Integr. Mol. Med."},{"key":"57154_CR31","doi-asserted-by":"publisher","first-page":"16581","DOI":"10.20452\/pamw.16581","volume":"133","author":"M Kiluk","year":"2023","unstructured":"Kiluk, M. et al. Alterations of the kynurenine pathway in patients with type 1 diabetes are associated with metabolic control of diabetes. Pol. Arch. Intern. Med. 133, 16581. https:\/\/doi.org\/10.20452\/pamw.16581 (2023).","journal-title":"Pol. Arch. Intern. Med."},{"key":"57154_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/pedi.12524","volume":"19","author":"A Galderisi","year":"2018","unstructured":"Galderisi, A. et al. Metabolomics reveals new metabolic perturbations in children with type 1 diabetes. Pediatr. Diabetes 19, 59\u201367. https:\/\/doi.org\/10.1111\/pedi.12524 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"57154_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12020-009-9184-0","volume":"36","author":"S Wang","year":"2009","unstructured":"Wang, S. et al. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves\u2019 disease. Endocrine 36, 119\u2013125. https:\/\/doi.org\/10.1007\/s12020-009-9184-0 (2009).","journal-title":"Endocrine"},{"key":"57154_CR34","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1210\/jc.2013-1273","volume":"98","author":"S Leskela","year":"2013","unstructured":"Leskela, S. et al. Plasmacytoid dendritic cells in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 98, 2822\u20132833. https:\/\/doi.org\/10.1210\/jc.2013-1273 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57154_CR35","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1210\/clinem\/dgad004","volume":"108","author":"HO Ueland","year":"2023","unstructured":"Ueland, H. O. et al. Systemic activation of the kynurenine pathway in Graves Disease with and without ophthalmopathy. J. Clin. Endocrinol. Metab. 108, 1290\u20131297. https:\/\/doi.org\/10.1210\/clinem\/dgad004 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57154_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/11786469221126063","author":"AS Pires","year":"2022","unstructured":"Pires, A. S. et al. Temporal profile of kynurenine pathway metabolites in a rodent model of autosomal recessive polycystic kidney disease. Int. J. Tryptophan Res. https:\/\/doi.org\/10.1177\/11786469221126063 (2022).","journal-title":"Int. J. Tryptophan Res."},{"key":"57154_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/IJTR.S4282","volume":"3","author":"LG Darlington","year":"2010","unstructured":"Darlington, L. G. et al. On the biological importance of the 3-hydroxyanthranilic acid: Anthranilic acid ratio. Int. J. Tryptophan Res. 3, 51\u201359. https:\/\/doi.org\/10.4137\/IJTR.S4282 (2010).","journal-title":"Int. J. Tryptophan Res."},{"key":"57154_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/bj0530513","volume":"53","author":"F Charconnet-Harding","year":"1953","unstructured":"Charconnet-Harding, F., Dalgliesh, C. E. & Neuberger, A. The relation between riboflavin and tryptophan metabolism, studied in the rat. Figure Biochem. J. 53, 513\u2013521. https:\/\/doi.org\/10.1042\/bj0530513 (1953).","journal-title":"Figure Biochem. J."},{"key":"57154_CR39","first-page":"198","volume":"29","author":"ZH Verjee","year":"1975","unstructured":"Verjee, Z. H. Tryptophan metabolism in baboons: Effect of riboflavin and pyridoxine deficiency. Figure Acta Vitaminol. Enzymol. 29, 198\u2013201 (1975).","journal-title":"Figure Acta Vitaminol. Enzymol."},{"key":"57154_CR40","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/S0007114514001858","volume":"112","author":"D Theofylaktopoulou","year":"2014","unstructured":"Theofylaktopoulou, D. et al. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-\u03b3-mediated immune activation in the community-based Hordaland Health Study. Br. J. Nutr. 112, 1065\u20131072. https:\/\/doi.org\/10.1017\/S0007114514001858 (2014).","journal-title":"Br. J. Nutr."},{"key":"57154_CR41","doi-asserted-by":"publisher","first-page":"618213","DOI":"10.3389\/fendo.2021.618213","volume":"12","author":"L Frommer","year":"2021","unstructured":"Frommer, L. & Kahaly, G. J. Type 1 diabetes and autoimmune thyroid disease-the genetic link. Front. Endocrinol. (Lausanne) 12, 618213. https:\/\/doi.org\/10.3389\/fendo.2021.618213 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"57154_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02591578","volume":"13","author":"HS Cole","year":"1976","unstructured":"Cole, H. S., Lopez, R. & Cooperman, J. M. Riboflavin deficiency in children with diabetes mellitus. Figure Acta Diabetol. Lat. 13, 25\u201329. https:\/\/doi.org\/10.1007\/BF02591578 (1976).","journal-title":"Figure Acta Diabetol. Lat."},{"key":"57154_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/S0004-27302013000300005","volume":"57","author":"G de Carvalho","year":"2013","unstructured":"de Carvalho, G., Perez, C. & Ward, L. The clinical use of thyroid function tests. Arq. Bras. Endocrinol. Metabol. 57, 193\u2013204. https:\/\/doi.org\/10.1590\/S0004-27302013000300005 (2013).","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"57154_CR44","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/clinchem\/43.8.1392","volume":"43","author":"V Kaczur","year":"1997","unstructured":"Kaczur, V. et al. Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin. Chem. 43, 1392\u20131396 (1997).","journal-title":"Clin. Chem."},{"key":"57154_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/a-0717-5514","volume":"50","author":"DE Williams","year":"2018","unstructured":"Williams, D. E., Le, S. N., Godlewska, M., Hoke, D. E. & Buckle, A. M. Thyroid peroxidase as an autoantigen in Hashimoto\u2019s Disease: Structure, function, and antigenicity. Horm. Metab. Res. 50, 908\u2013921. https:\/\/doi.org\/10.1055\/a-0717-5514 (2018).","journal-title":"Horm. Metab. Res."},{"key":"57154_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-00431","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi, B. & Cooper, D. S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76\u201313. https:\/\/doi.org\/10.1210\/er.2006-00431 (2008).","journal-title":"Endocr. Rev."},{"key":"57154_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03234.x","volume":"147","author":"L Brent","year":"2007","unstructured":"Brent, L. et al. Crystal-ball gazing-the future of immunological research viewed from the cutting edge. Clin. Exp. Immunol. 147, 1\u201310. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03234.x (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"57154_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/jaut.1999.0272","volume":"12","author":"H Braley-Mullen","year":"1999","unstructured":"Braley-Mullen, H., Sharp, G. C., Medling, B. & Tang, H. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 12, 157\u2013165. https:\/\/doi.org\/10.1006\/jaut.1999.0272 (1999).","journal-title":"J. Autoimmun."},{"key":"57154_CR49","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/en.2008-0702","volume":"150","author":"M Nakahara","year":"2009","unstructured":"Nakahara, M. et al. Expression of immunoregulatory molecules by thyrocytes protects nonobese diabetic-H2h4 mice from developing autoimmune thyroiditis. Endocrinology 150, 1545\u20131551. https:\/\/doi.org\/10.1210\/en.2008-0702 (2009).","journal-title":"Endocrinology"},{"key":"57154_CR50","doi-asserted-by":"publisher","first-page":"110288","DOI":"10.1016\/j.biopha.2020.110288","volume":"128","author":"H Qiu","year":"2020","unstructured":"Qiu, H., Zhang, J., Guo, Q., Zhang, Y. & Zhong, X. Prunella vulgaris L. attenuates experimental autoimmune thyroiditis by inducing indoleamine 2,3-dioxygenase 1 expression and regulatory T cell expansion. Biomed. Pharmacother. 128, 110288. https:\/\/doi.org\/10.1016\/j.biopha.2020.110288 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"57154_CR51","doi-asserted-by":"publisher","first-page":"1180537","DOI":"10.3389\/fmolb.2023.1180537","volume":"10","author":"X Fan","year":"2023","unstructured":"Fan, X. et al. Metabolic profiling reveals altered tryptophan metabolism in patients with kawasaki disease. Front. Mol. Biosci. 10, 1180537. https:\/\/doi.org\/10.3389\/fmolb.2023.1180537 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"57154_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biochi.2018.06.009","volume":"152","author":"RE Silva","year":"2018","unstructured":"Silva, R. E. et al. Predictive metabolomic signatures of end-stage renal disease: A multivariate analysis of population-based data. Biochimie 152, 14\u201330. https:\/\/doi.org\/10.1016\/j.biochi.2018.06.009 (2018).","journal-title":"Biochimie"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57154-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:15:32Z","timestamp":1711034132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-57154-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["57154"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-57154-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6851"}}